DZ Bank

DZ Bank’s Redhill Biopharma RDHL Stock Holding History

DZ Bank’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19	Closed	-$96K	–	1040
2018 Q1	$96K	Buy	+19	New	+$109K	﹤0.01%	1008
2017 Q3	–	Sell	-14	Closed	-$117K	–	934
2017 Q2	$117K	Buy	+14	New	+$135K	﹤0.01%	768

Other funds holding RDHL

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Creative Planning

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

DZ Bank's RDHL Position: Q2 2018 in Review

DZ Bank sold out of Redhill Biopharma (RDHL) in Q2 2018, closing a stake of 19 shares — an estimated $96K sold.

DZ Bank first reported a position in RDHL in Q2 2017 and held it in 2 quarters. The position peaked at $117K in Q2 2017. 30 funds tracked by Wall St. Rank hold RDHL as of Q2 2018.

DZ Bank reported no remaining Redhill Biopharma position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 19 Redhill Biopharma shares in Q2 2018, an estimated $96K.
DZ Bank first reported a position in Redhill Biopharma in Q2 2017 and held it in 2 quarters.
DZ Bank's Redhill Biopharma position peaked at $117K in Q2 2017.
30 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.